Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Tofacitinib may help regrow hair in alopecia areata patients.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Baricitinib helps treat severe hair loss in people over 65.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.